T1952 |
MK-2206 dihydrochloride |
Cytoskeletal signaling; PI3K/Akt/mTOR signaling |
Akt |
Akt1; Akt2; Akt3 |
T3132 |
SC66 |
Cytoskeletal signaling; PI3K/Akt/mTOR signaling |
Akt inhibitor |
Akt |
T2492 |
Perifosine |
Cytoskeletal signaling; PI3K/Akt/mTOR signaling |
Akt inhibitor |
Akt |
T4489 |
AZD26 |
PI3K/Akt/mTOR signaling; cytoskeletal signaling |
Akt inhibitor |
Allosteric Akt |
T1961 |
Vistusertib |
Cytoskeletal Signaling; PI3K/Akt/mTOR signaling; MAPK |
Akt inhibitor; mTOR inhibitor; PI3K inhibitor; S6 Kinase inhibitor |
P-Akt (S473); mTOR; PI3Kα; pS6 (S235/236) |
T1936 |
Alectinib |
Angiogenesis; tyrosine kinase/adaptors; tyrosine kinase/adaptors |
ALK inhibitor; tyrosine kinases inhibitor; VEGFR inhibitor |
ALK; ALK (F1174L); ALK (R1275Q); INSR; VEGFR2 (KDR) |
T1661 |
Crizotinib |
Angiogenesis; tyrosine kinase/adaptors |
ALK; c-Met/HGFR |
ALK; c-Met |
T16156 |
MT 63-78 |
PI3K/Akt/mTOR signaling |
AMPK; mTOR |
AMPK;mTORC1 |
T2235 |
Dactolisib |
DNA damage/DNA repair; PI3K/Akt/mTOR signaling |
ATM/ATR; mTOR; PI3K |
ATR; mTOR (p70 S6K); p110α; p110γ; p110δ |
T2509 |
Tozasertib |
Cell cycle/checkpoint; chromatin/epigenetic |
Aurora Kinase |
Aurora A; Aurora B; Aurora C |
T6315 |
MLN8054 |
Cell cycle/checkpoint; metabolism; angiogenesis; GPCR/G protein; chromatin/epigenetic; stem cells |
Aurora kinase inhibitor; casein kinase inhibitor; PKA inhibitor; Src inhibitor |
Aurora A; Aurora B; CK2; PKA; Lck |
T6458 |
CYC116 |
Cell cycle/checkpoint; angiogenesis; PI3K/Akt/mTOR signaling; chromatin/epigenetic; tyrosine kinase/adaptors; MAPK |
Aurora Kinase inhibitor; CDK inhibitor; FLT inhibitor; S6 Kinase inhibitor; VEGFR inhibitor |
Aurora A; Aurora B; CDK2/CyclinE; CDK9/CyclinT; FLT3; p70 S6K; VEGFR2 |
T2358 |
ENMD2076 |
Cell cycle/checkpoint; angiogenesis; apoptosis; chromatin/epigenetic; tyrosine kinase/adaptors |
Aurora kinase inhibitor; c-RET inhibitor;FLT inhibitor; Src inhibitor; VEGFR inhibitor |
Aurora A; RET; FLT3; Src; VEGFR3/FLT4; Src |
T2378 |
RGB-286638 free base |
Cell cycle/checkpoint |
CDK inhibitor |
CDK1/cyclinB1; CDK2/cyclinE; CDK3/cyclinE; CDK4/cyclin D1; CDK9/cyclinT1; p35-CDK5 |
T2029 |
Bohemine |
Cell cycle/checkpoint |
CDK inhibitor |
CDK |
T2247 |
KenPaullone |
PI3K/Akt/mTOR signaling; cell cycle/checkpoint; stem cells |
CDK inhibitor; GSK-3 inhibitor |
CDK1/CyclinB; CDK2/CyclinA; CDK2/CyclinE; CDK5/p35; GSK-3β |
T1778 |
AT 7519 hydrochloride salt |
PI3K/Akt/mTOR signaling; cell cycle/checkpoint; stem cells |
CDK inhibitor; GSK-3 inhibitor |
CDK2/CyclinA; CDK4/Cyclin D1; CDK5/p35; CDK9/CyclinT; GSK-3β |
T4327 |
Prexasertib dihydrochloride |
Cell cycle/checkpoint; PI3K/Akt/mTOR signaling; MAPK |
Chk; S6 Kinase |
Chk1;Chk2;RSK |
T4301 |
AD80 |
Tyrosine kinase/adaptors; MAPK; angiogenesis; PI3K/Akt/mTOR signaling; apoptosis |
c-RET; Raf; Src; S6 Kinase |
RET, RAF, SRC, S6K;RET V804M;RET V804L |
T3458 |
EED226 |
Chromatin/epigenetic |
DNA methyltransferase inhibitor; Histone methyltransferase inhibitor |
EED; PRC2 |
T2377 |
XL147 analogue |
DNA damage/DNA repair; PI3K/Akt/mTOR signaling |
DNA-PK inhibitor; PI3K inhibitor |
DNA-PK; PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ |
T1826 |
Voxtalisib Analogue |
DNA damage/DNA repair; PI3K/Akt/mTOR signaling |
DNA-PK inhibitor; PI3K inhibitor |
DNA-PK; PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ |
T14073 |
A-485 |
Chromatin/epigenetic |
Epigenetic Reader Domain; Histone Acetyltransferase |
CBP/p300;histone acetyltransferase |
T2608 |
CHIR98014 |
PI3K/Akt/mTOR signaling; angiogenesis; stem cells; tyrosine kinase/adaptors; MAPK |
FGFR inhibitor; GSK-3 inhibitor; S6 Kinase inhibitor; Src inhibitor |
bFGFR; GSK-3α; GSK-3β; p70 S6K; c-Src |
T2310 |
CHIR99021 |
PI3K/Akt/mTOR signaling; stem cells |
GSK-3 |
GSK-3α; GSK-3β |
T1741 |
AZD1080 |
PI3K/Akt/mTOR signaling; stem cells |
GSK-3 inhibitor |
GSK-3α; GSK-3β |
T1755 |
LY2090314 |
PI3K/Akt/mTOR signaling; stem cells |
GSK-3 inhibitor |
GSK-3α; GSK-3β |
T3067 |
Tideglusib |
PI3K/Akt/mTOR signaling; stem cells |
GSK-3 inhibitor |
GSK-3β |
T1881 |
AR-A014418 |
PI3K/Akt/mTOR signaling; stem cells |
GSK-3 inhibitor |
GSK-3β; GSK-3β |
T1957 |
AZD2858 |
PI3K/Akt/mTOR signaling; stem cells |
GSK-3 inhibitor |
GSK-3 |
T6187 |
TDZD8 |
PI3K/Akt/mTOR signaling; stem cells |
GSK-3 inhibitor |
GSK-3β |
T6059 |
GSK343 |
Chromatin/epigenetic |
Histone methyltransferase inhibitor |
EZH1; EZH2 |
T3057 |
UNC1999 |
Chromatin/epigenetic |
Histone methyltransferase inhibitor |
EZH1; EZH2 |
T1788 |
EPZ6438 |
Chromatin/epigenetic |
Histone methyltransferase inhibitor |
EZH2; EZH2 |
T4583 |
(R)-PFI-2 hydrochloride |
Chromatin/epigenetic |
Histone methyltransferase inhibitor |
SETD7 |
T1841 |
UNC0379 |
Chromatin/epigenetic |
Histone methyltransferase inhibitor |
SETD8 |
T2243 |
Serdemetan |
Apoptosis |
Mdm2 inhibitor; p53 activator |
HDM2; Mdm2; p53 |
T6159 |
LY-2584702 free base |
PI3K/Akt/mTOR signaling |
mTOR |
mTOR (p70 S6K) |
T1859 |
AZD8055 |
PI3K/Akt/mTOR signaling |
mTOR |
mTOR |
T2706 |
Palomid 529 |
PI3K/Akt/mTOR signaling |
mTOR inhibitor |
mTORC1; mTORC2 |
T1838 |
INK 128 |
PI3K/Akt/mTOR signaling |
mTOR inhibitor; PI3K inhibitor |
mTOR; mTOR; PI3Kα; PI3Kγ; PI3Kδ |
T3153 |
Serabelisib |
PI3K/Akt/mTOR signaling |
mTOR inhibitor; PI3K inhibitor |
mTOR; p110α; p110β; p110γ; p110δ |
T1916 |
Apitolisib |
PI3K/Akt/mTOR signaling |
mTOR inhibitor; PI3K inhibitor |
mTOR; p110α; p110β; p110γ; p110δ |
T2357 |
GSK1059615 |
PI3K/Akt/mTOR signaling |
mTOR inhibitor; PI3K inhibitor |
mTOR; PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ |
T1861 |
Omipalisib |
PI3K/Akt/mTOR signaling |
mTOR inhibitor; PI3K inhibitor |
mTORC1; p110α; p110β; p110γ; p110δ |
T2619 |
CH5132799 |
PI3K/Akt/mTOR signaling |
mTOR inhibitor; PI3K inhibitor |
mTOR; PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ |
T1970 |
Gedatolisib |
PI3K/Akt/mTOR signaling |
mTOR inhibitor; PI3K inhibitor |
mTOR; PI3Kα; PI3Kγ |
T2265 |
PI3K-IN-2 |
Others; PI3K/Akt/mTOR signaling; MAPK |
Others inhibitor;S6 Kinase inhibitor;PI3K;mTOR |
pPKB; pS6;PI3Kα;PI3Kβ;mTOR;PI3Kγ;PI3Kδ |
T1827 |
Buparlisib |
PI3K/Akt/mTOR signaling |
PI3K |
p110α; p110β; p110γ; p110δ; Vps34 |
T1994 |
Pictilisib |
PI3K/Akt/mTOR signaling |
PI3K |
p110α; p110β; p110γ; p110δ |
T2672 |
TG100-115 |
PI3K/Akt/mTOR signaling |
PI3K inhibitor |
PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ |
T2365 |
Pilaralisib |
PI3K/Akt/mTOR signaling |
PI3K inhibitor |
PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ |
T2073 |
GSK2636771 |
PI3K/Akt/mTOR signaling |
PI3K inhibitor |
PI3Kβ |
T6168 |
ZSTK474 |
PI3K/Akt/mTOR signaling |
PI3K inhibitor |
PI3K; PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ |
T1988 |
Duvelisib |
PI3K/Akt/mTOR signaling |
PI3K inhibitor |
PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ |
T1999 |
Taselisib |
PI3K/Akt/mTOR signaling; metabolism |
PI3K inhibitor; Carbonic Anhydrase |
PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ;C2β |
T2008 |
LY294002 |
PI3K/Akt/mTOR signaling; DNA damage/DNA repair |
PI3K; DNA-PK |
p110α; p110β; p110δ;DNA-PK |
T6250 |
H 89 2HCl |
GPCR/G protein; PI3K/Akt/mTOR signaling; MAPK |
PKA; S6 kinase |
PKA; S6K1 |
T3518 |
GSK269962A |
Cell cycle/checkpoint; cytoskeletal signaling; PI3K/Akt/mTOR signaling; stem cells; MAPK |
ROCK inhibitor; S6 kinase inhibitor |
MSK1; ROCK1; ROCK2; RSK1 |
TN1712 |
Gossypin |
PI3K/Akt/mTOR signaling; MAPK |
S6 kinase |
RSK2 |
T6S1302 |
Carnosol |
PI3K/Akt/mTOR signaling; MAPK |
S6 kinase |
RSK2 |
T22422 |
S6K-18 |
PI3K/Akt/mTOR signaling; MAPK |
S6 kinase |
S6K1 |
T2002 |
PF4708671 |
PI3K/Akt/mTOR signaling; MAPK |
S6 kinase inhibitor |
p70 S6K |
T1746 |
LY-2584702 tosylate |
PI3K/Akt/mTOR signaling; MAPK |
S6 kinase inhibitor |
p70 S6K |
T6877 |
LJH685 |
PI3K/Akt/mTOR signaling; MAPK |
S6 kinase inhibitor |
RSK1; RSK2; RSK3 |
T6878 |
LJI308 |
PI3K/Akt/mTOR signaling; MAPK |
S6 kinase inhibitor |
RSK1; RSK2;RSK3 |
T4488 |
GSK25 |
PI3K/Akt/mTOR signaling; PI3K/Akt/mTOR signaling; MAPK |
S6 kinase inhibitor; mTOR inhibitor |
RSK1; mTOR (p70 S6K) |
T5428 |
BIX 02565 |
PI3K/Akt/mTOR signaling; autophagy; MAPK |
S6 kinase; LRRK2 |
RSK2;LRRK2 |
T2510 |
Galunisertib |
Stem cells |
TGF-beta/Smad |
TβRI |
T1293 |
Gatifloxacin |
DNA damage/DNA repair |
Topoisomerase inhibitor |
Topo IV |
T1878 |
XAV939 |
Stem cells; cytoskeletal signaling |
Wnt/beta-catenin |
TNKS1; TNKS2 |
T2237 |
ICG001 |
Cytoskeletal signaling; stem cells; chromatin/epigenetic |
Wnt/beta-catenin inhibitor; Epigenetic Reader Domain |
Wnt/β-catenin; CBP |
T2436 |
GSK2801 |
Chromatin/epigenetic |
Epigenetic Reader Domain inhibitor |
BAZ2A/2B |
T6668 |
SGC-CBP30 |
Chromatin/epigenetic |
CREBBP/EP300 inhibitor |
CREBBP/EP300 |
T2452 |
C646 |
Chromatin/epigenetic |
Histone acetyltransferase inhibitor |
p300/CBP |
T6133 |
Remodelin |
Chromatin/epigenetic |
Histone acetyltransferase inhibitor |
Acetyltransferase NAT10 |